Both in Pharmaceuticals
Erasca vs Veradermics, Incorporated
Over the past year ERAS returned +26.4% and MANE returned +212.1%; their daily moves had a correlation of 0.01.
ERAS +26.4% MANE +212.1%Growth of $1, one year, split-adjusted
| Metric | ERAS | MANE |
|---|---|---|
| Price | $14.21 | $117.82 |
| Market cap | $4.97B | $4.92B |
| Today | +0.57% | +2.45% |
| 1 month | −21.2% | +20.3% |
| 6 months | −4.9% | +93.6% |
| Year to date | +282.0% | — |
| 1 year | +583.2% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $268.7M | $819.9M |
| Dividend yield | — | — |
| Volatility (60d) | 60.0% | 66.0% |
| Short % of float | 13.2% | 17.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).